Compare ANL & ODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | ODD |
|---|---|---|
| Founded | 2004 | 2018 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.8M | 973.7M |
| IPO Year | 2022 | 2022 |
| Metric | ANL | ODD |
|---|---|---|
| Price | $10.00 | $15.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 11 |
| Target Price | ★ $29.50 | $16.94 |
| AVG Volume (30 Days) | 229.1K | ★ 838.0K |
| Earning Date | 08-14-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $243.83 | N/A |
| Revenue Next Year | N/A | $11.75 |
| P/E Ratio | ★ N/A | $16.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $9.25 |
| 52 Week High | $17.25 | $46.45 |
| Indicator | ANL | ODD |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 34.39 |
| Support Level | $8.95 | $11.51 |
| Resistance Level | $11.75 | $15.72 |
| Average True Range (ATR) | 1.03 | 1.90 |
| MACD | 0.20 | -0.73 |
| Stochastic Oscillator | 42.35 | 2.35 |
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.